姓名：李雁 性别：男 职称：主任医师、教授 招生院所：附属世纪坛医院 招生类型：科学与专业学位(博) 科学与专业学位(硕) 招生专业：肿瘤学(博) 肿瘤学(硕) 研究方向名称：肿瘤转移与复发综合防治新技术的基础与临床研究 电子信箱：liyansd2@163.com


社会任职
1. 《中华实验外科杂志》特约审稿人
2. 《中华医学杂志英文版》特约审稿人
3. 《中国医学论坛报－新英格兰医学杂志》特约译稿人
4. 《中华医学杂志》特约通讯员
5. 《中国肿瘤临床》编委会委员
6. 《Biomaterials杂志》副主编
7. 湖北省医师协会肿瘤医师分会第一届第一届委员会副主任委员
8. 湖北省医学会肿瘤学分会第六届委员会委员
9. 湖北省生物医学工程学会肿瘤靶向治疗专业委员会副主任委员
10. 湖北省抗癌协会第五、六届理事会常务理事
11. 中国抗癌协会纳米肿瘤学专业委员会第一届委员会常务委员
12. 中国抗癌协会肿瘤转移委员会第三届委员
13. 中国生物材料学会常务理事
14. 美国临床肿瘤学会（ASCO）会员
15. 腹膜表面肿瘤学国际联盟（PSOGI）中国地区常委
16. 国际外科、消化和肿瘤医师协会（IASGO）会员
17. 中国抗癌协会肿瘤转移专业委员会委员
18. 中国医师协会放射肿瘤治疗医师分会常委
19. 中国抗癌协会肿瘤热疗专业委员会常务委员
20. 中国抗癌协会腹膜肿瘤专业委员会副主任委员
个人简历
1. 199108-199407:白求恩医科大学 学习
2. 199408-199608:山东省新泰市第二人民医院 任职
3. 199608-199907:武汉大学医学院 学习
4. 199908-200207:复旦大学上海医学院 学习
5. 200207-200307:复旦大学中山医院 任职
6. 200307-201504:武汉大学中南医院 任职
7. 200609-200612:日本福岛医科大学 学习
8. 200805-200806:美国Karmanos癌症中心 学习
9. 201504-:首都医科大学附属北京世纪坛医院 任职
重要学术论文
1. Lin YL, Zhang J, Yan FC, Jiang X, Ma R, Yang ZR, Xu HB, Peng Z, Chen Q, Li Y*.Establishment of ptient-derived xenograft model of peritoneal mucinous carcinomatosis with signet ring cells and in vivo study on the efficacy and toxicity of intraperitoneal injection of 5-fluorouracil. Cancer Medicine. 2020,9(3):1104-1114.SCI
2. Yan FC,Lin YL, Zhou Q, Chang H, Li Y*.Pathological Prognostic Factors of Pseudomyxoma Peritonei:Comprehensive Clinicopathological Analysis of 155 Cases. Hum Pathol. 2020,97:9-18.SCI
3. Li XB, Ma R, Ji ZH, Lin YL, Zhang J, Yang ZR, Chen LF, Yan FC, Li Y*.Perioperative safety after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei from appendiceal origin: Experience on 254 patients from a single center. Eur J Surg Oncol. 2020,46(4 Pt A):600-606.SCI
4. Li XB, Peng KW, Ji ZH, Yu Y, Liu G, Li Y*.Prevention of Venous Thromboembolism After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Development of a Physiotherapy Program. Clin Appl Thromb Hemost. 2019,25:90415.SCI
5. 闫风彩, 李鑫宝, 林育林, 余春开, 周全, 李雁*.卵巢来源腹膜假黏液瘤临床病理分析. 中国肿瘤临床. 2019,46(17):887-890.核心期刊
6. 闫风彩, 林育林, 赵洪禹, 周全, 昌红, 李雁*.腹膜假黏液瘤155例病理预后因素分析. 中华病理学杂志. 2019,48(7):543-549.核心期刊
7. 林育林, 张珏, 杨智冉, 李鑫宝, 姬忠贺, 许洪斌, 彭正, 李雁*.腹膜假黏液瘤人源异种移植模型的研究进展. 医学综述. 2019,25(14):2842-2849.
8. 姬忠贺, 李雁*.胃癌腹膜转移的研究进展. 中华普通外科杂志. 2019,34(10):825-827.
9. 杜雪梅, 李鑫宝, 马玲, 高颖, 孙萍萍, 李雁*.腹膜恶性间皮瘤中肿瘤浸润淋巴细胞和Ki-67表达与临床病理特征及预后的关系. 临床与实验病理学杂志. 2019,35(8):920-928.核心期刊
10. Li XB, Ji ZH, Li Y*.Peritoneal Carcinomatosis Diagnosis and Treatment in China: Focusing on Training and Collaboration. Indian Journal of Surgical Oncology. 2019,10(Suppl 1):12-18.
11. 林育林, 张珏, 闫风彩, 蒋茜, 马茹, 杨智冉, 李雁*.腹腔注射5-氟尿嘧啶治疗腹膜假黏液瘤的人源异种移植模型. 中华实验外科杂志. 2019,36(10):1798-1801.核心期刊
12. 林育林, 张珏, 杨智冉, 李鑫宝, 姬忠贺, 许洪斌, 闫风彩, 周全, 彭正, 李雁*.腹膜高级别黏液癌伴印戒细胞裸小鼠模型的建立及生物学功能鉴定. 中华肿瘤杂志. 2019,41(12):923-931.核心期刊
13. 姬忠贺, 于洋, 刘刚, 张彦斌, 李兵, 安松林, 李鑫宝, 李雁*.肿瘤细胞减灭术加腹腔热灌注化疗治疗胃癌腹膜转移的预后列线图构建与验证. 中华普通外科杂志. 2019,34(10):833-836.
14. 李鑫宝, 姬忠贺, 于洋, 张彦斌, 刘刚, 李兵, 张凯, 李雁*.肿瘤细胞减灭术加腹腔热灌注化疗治疗阑尾腺癌腹膜癌的临床研究. 实用肿瘤杂志. 2019,34(01):66-71.核心期刊
15. Ji ZH, An SL, Li XB, Liu G, Li Y*.Long-term progression-free survival of hepatocellular carcinoma with synchronous diffuse peritoneal metastasis treated by CRS+HIPEC: A case report and literature review. Medicine. 2019,98(8）:e14628.SCI
16. 姬忠贺, 李雁*.胃癌腹膜转移的研究进展. 中华普通外科杂志. 2019,34(10):825-827.
17. 李鑫宝，姬忠贺，张彦斌，刘刚，李兵，安松林，于洋，张凯，林育林，李雁*.肿瘤细胞减灭术加腹腔热灌注化疗围手术期静脉血栓栓塞症的危险因素及防治技术. 肿瘤防治研究. 2019,46(2):121-126.
18. 张珏,梅列军, 汪付兵, 李雁*.卵巢癌肿瘤细胞减灭术加腹腔热灌注化疗疗远期无瘤生存一例报告并文献复习. 中华肿瘤防治杂志. 2019,26(20):1574-1578.核心期刊
19. 张珏, 李鑫宝, 姬忠贺, 马茹, 李雁*.倾向性评分匹配评估肿瘤细胞减灭术联合腹腔热灌注化疗治疗晚期卵巢癌的疗效. 中国肿瘤临床. 2019,46(19):994-998.核心期刊
20. 李雁*, 许洪斌, 彭正, 崔书中, 吴畏, 梁寒, 朱正纲, 陆维祺, 李子禹, 徐惠绵, 刘骞, 赵赟博, 梁斌, 丁克峰, 吴玉梅, 张震宇, 杨国梁, 杨肖军, 周全, 卢一艳, 魏少忠.肿瘤细胞减灭术加腹腔热灌注化疗治疗腹膜假黏液瘤专家共识. 中华医学杂志. 2019,99(20):1527-1535.核心期刊
21. 李鑫宝, 姬忠贺, 林育林, 李雁*.细胞减灭术联合腹腔热灌注化疗治疗腹膜假黏液瘤的研究进展. 医学综述. 2019,25(5):915-921.
22. 姬忠贺, 李雁*.第十一届国际腹膜癌大会简况与思考. 中华医学杂志. 2019,99(2):158-160.核心期刊
23. 姬忠贺, 李鑫宝, 刘刚, 于洋, 林育林, 张彦斌, 李雁*. 肿瘤细胞减灭术加腹腔热灌注化疗治疗110例胃癌腹膜癌临床分析. 中华医学杂志. 2018,98(38):3097-3083.核心期刊
24. 刘刚, 李鑫宝, 姬忠贺, 刘勇, 张敏, 王勇, 李雁*.D-二聚体联合凝血酶时间检查对腹膜癌患者下肢深静脉血栓排除的诊断价值. 中国普通外科杂志. 2018,27(06):740-746.核心期刊
25. 林育林, 姬忠贺, 李鑫宝, 赵东兵, 李子禹, 李雁*. 临床医师综合考评方法探析. 中华医学教育杂志. 2018,38(5):782-786.核心期刊
26. 孙建华，姬忠贺，李雁*.细胞减灭术加腹腔热灌注化疗治疗复发性卵巢癌. 肿瘤学杂志. 2018,24(3):240-246.核心期刊
27. Zhang J, Yuan JP, Wang Q, Shao LH, Liu SP, Firestone RA, Hong YP, Li JG, Xin YC, Li Y* .Experimental evidence of good efficacy and reduced toxicity with peptide-doxorubicin to treat gastric cancer. Oncotarget.. 2018,(9)2:1957-1968.
28. 姬忠贺, 刘洋, Yonemura Y, 李雁*.5-氨基酮戊酸光动力学诊断腹膜转移癌的研究进展. . 首都医科大学学报. 2018,39(3):469-475.核心期刊
29. Peng CW, Liu JY, Yang GF, Li Y*.The tumor-stromal ratio as a strong prognosticator for advanced gastric cancer patients: proposal of a new TSNM staging system. J Gastroenterol. 2018, 53(5): 606-617.SCI
30. 李鑫宝, 林育林, 姬忠贺, 李雁*. 肿瘤细胞减灭术加腹腔热灌注化疗治疗腹膜假黏液瘤182例分析. 中国肿瘤临床. 2018,45 (18):943-949.核心期刊
31. Fang M, Chen M, Liu LL, Li Y*.Applications of quantum dots in cancer detection and diagnosis: a review.. J Biomed Nanotechnol.. 2017,13(1):1-16.SCI
32. Wu H, Liu SP, Gong J, Liu JY, Zhang Q, Leng XH, Zhang N, Li Y*..VCPA, a novel synthetic derivative of α-tocopheryl succinate, sensitizes human gastric cancer to doxorubicin-induced apoptosis via ROS-dependent mitochondrial dysfunction.. Cancer Lett.. 2017,393:22-32.SCI
33. Huang CQ, Min Y, Wang SY, Yang XJ, Liu Y, Xiong B, Yonemura Y, Li Y*.Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival for peritoneal carcinomatosis from colorectal cancer: a systematic review and meta-analysis of current evidence.. Oncotarget. 2017,8(33):55657-55683.SCI
34. Liu JY, Peng CW, Yang GF, Hu WQ, Yang XJ, Xiong B, Li Y*.Distribution pattern of tumor associated macrophages predicts the prognosis of gastric cancer.. Oncotarget. 2017,8(54):92757-92769.SCI
35. Peng CW, Liu JY, Yang GF, Li Y*.The tumor-stromal ratio as a strong prognosticator for advanced gastric cancer patients: proposal of a new TSNM staging system.. J Gastroenterol.. 2017,(10):DOI: 10.1007/s00535-017-1379-1..SCI
36. Ji ZH, Peng KW, Yu Y, Li XB, Yonemura Y, Liu Y, Sugarbaker PH, Li Y*.Current status and future prospects of clinical trials on CRS  +  HIPEC for gastric cancer peritoneal metastases.. Int J Hyperthermia.. 2017,33(5):562-570.SCI
37. Yonemura Y*, Ishibashi H, Hirano M, Mizumoto A, Takeshita K, Noguchi K, Takao N, Ichinose M, Liu Y, Li Y.Effects of neoadjuvant laparoscopic hyperthermic intraperitoneal chemotherapy and neoadjuvant intraperitoneal/systemic chemotherapy on peritoneal metastases from gastric cancer.. Annals of Surgical Oncology. 2017,24(2):478–485.SCI
38. 张彦斌, 姬忠贺, 刘刚, 于洋, 李兵, 李鑫宝, 王岩, 张展志, 李雁*.双套管持续冲洗负压引流治疗腹膜癌术后胃肠瘘[J]. 中华普通外科杂志. 2017,32(6):505-507.核心期刊
39. Geng XF, Fang M, Liu SP, Li Y*.Quantum dot-based molecular imaging of cancer cell growth using a clone formation assasy.. Molecular Medicine Reports. 2016,4(14):3007-3012.SCI
40. Yan Li*, Yun-Feng Zhou, Han Liang, Hua-Qing Wang, Ji-Hui Hao, Zheng-Gang Zhu, De-Seng Wan, Lun-Xiu Qin, Shu-Zhong Cui, Jia-Fu Ji, Hui-Mian Xu, Shao-Zhong Wei, Hong-Bin Xu, Tao Suo, Shu-Jun Yang, Cong-Hua Xie, Xiao-Jun Yang, Guo-Liang Yang.Chinese expert consensus on cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis. . World J Gastroenterol. 2016,22(30):6906-6916.SCI
41. Yonemura Y*, Canbay E, Li Y, Coccolini F, Glehen O, Sugarbaker PH, Morris D, Moran B, Gonzaletz-Moreno S, Deraco M, Piso P, Elias D, Batlett D, Ishibashi H, Mizumoto A, Verwaal V, Mahtem H..A comprehensive treatment for peritoneal metastases from gastric cancer with curative intent.. European Journal of Surgical Oncology . 2016,42(8):1123–1131.SCI
42. Wu HT, Peng KW, Ji ZH, Sun JH, Zhang Q, Yang XJ, Huang CQ, Li Y*.Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel to treat synchronous peritoneal carcinomatosis from gastric cancer: results from a Chinese center.. European Journal of Surgical Oncology . 2016,7(42):1024–1034.SCI
43. Zhonghe Ji, Jianhua Sun, Haitao Wu, Qian Zhang, Kaiwen Peng, Yan Li*.Assessment of Hyperthermic Inreaperitoneal Chemotherapy to Eradicate Intraperitoneal Free Cancer Cells.. Translational Oncology. 2016,9(1):18-24.SCI
44. 6.Jianhua Sun, Zhonghe Ji, Yang Yu, Haitao Wu, Chaoqun Huang, Qian Zhang, Xiaojun Yang, Yutaka Yonemura, Yan Li*.Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy to Treat Advanced/Recurrent EpithelialOvarian Cancer: Results from a Retrospective Study on Prospectively Established Database.. Translational Oncology. 2016,9(2):130-137.SCI
45. Jianhua Sun, Zhonghe Ji, Kaiwen Peng, Haitao Wu, Qian Zhang, Yukata Yonemura, Yan Li*.Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy for the treatment of primary peritoneal serous carcinoma: Results of a Chinese retrospective study.. International Journal of Hyperthermia. 2016,16:1-9.SCI
46. Linwei Wang, Aiping Ou, Wenlou Liu, Jiamei Chen, Jingping Yuan, Han Wu, Yan Li*, Juan Liu..Quantum dots-based double imaging combined with organic dye imaging to establish an automatic computerized method for cancer Ki67 measurement.. Scientific Reports. 2016,6:20564.SCI
47. Jiuyang Liu, Xiafei Geng, Yan Li*.Milky spots: omental functional units and hotbeds for peritoneal cancer metastasis.. Tumor biology. 2016,37(5):5715-26.SCI
48. Zeng WJ, Peng CW, Yuan JP, Cui R, Li Y*.Quantum dot-based multiplexed imaging in malignant ascites: a new model for malignant ascites classification.. Int J Nanomedicine. 2015,10:1759-68.SCI
49. Sun J, Chen C, Wei W, Zheng H, Yuan J, Tu YI, Yao F, Wang L, Yao X, Li J, Li Y*, Sun S..Associations and indications of Ki67 expression with clinicopathological parameters and molecular subtypes in invasive breast cancer: A population-based study . Oncol Lett. 2015,10(3):1741-1748.SCI
50. Hu M, Li K, Maskey N, Xu Z, Yu F, Peng C, Li Y*, Yang G.Overexpression of the chemokine receptor CXCR3 and its correlation with favorable prognosis in gastric cancer. Hum Pathol. 2015,46(12):1872-80.SCI
51. Wang XY, Pei Y, Xie M, Jin ZH, Xiao YS, Wang Y, Zhang LN, Li Y, Huang WH.Artificial blood vessel implanted three-dimensional microsystem for modeling transvascular migration of tumor cells. Lab Chip. 2015,15(4):1178-87.SCI
52. Qu AP, Chen JM, Wang LW, Yuan JP, Yang F, Xiang QM, Maskey N, Yang GF, Liu J, Li Y* .Segmentation of Hematoxylin-Eosin stained breast cancer histopathological images based on pixel-wise SVW classifier. Science China Information Sciences. 2015,58(9):092105:1-092105:13..SCI
53. Wei YH, Zhou FX, Li Y, Zhou YF, Anish K, Xu LY, Liao MY.Extrapleural locating method in computed tomography-guided needle biopsies of 1,106 lung lesions . Exp Ther Med. 2015,10(5):1707-1719.SCI
54. Hu M, Li K, Maskey N, Xu Z, Peng C, Tian S, Li Y, Yang G.15-PGDH expression as a predictive factor response to neoadjuvant chemotherapy in advanced gastric cancer. International Journal of Clinical and Experimental Pathology. 2015,8(6):6910-6918.SCI
55. Xu H, Chen C, He Y, Tang HW, Zhang ZL, Li Y*, Pang DW.Analysis of cancer marker in tissues with Hadamard transform fluorescence spectral microscopic imaging. J Fluoresc. 2015,25(2):397-402.SCI
56. Liu WL, Wang LW, Chen JM, Yuan JP, Xiang QM, Yang GF, Qu AP, Liu J, Li Y*.Application of multispectral imaging in quantitative immunohistochemistry study of breast cancer: a comparative study. Tumour Biol. 2015,37(4):5013-24.SCI
57. Tan Y, Li Y*.HCV core protein promotes hepatocyte proliferation and chemoresistance by inhibiting NR4A1. Biochem Biophys Res Commun. 2015,466（3）:592-598.SCI
58. Chen JM, Qu AP, Wang LW, Yuan JP, Yang F, Xiang QM, Maskey N, Yang GF, Liu J, Li Y*.New breast cancer prognostic factors identified by computer-aided image analysis of HE stained histopathology images. Scientific Reports. 2015,29(5):10690.SCI
59. Zeng WJ, Peng CW, Yuan JP, Cui R, Li Y#.Quantum dot-based multiplexed imaging in malignant ascites: a new model for malignant ascites classification. International Journal of Nanomedicine. 2015,10:1759-1768.SCI
60. Xiang QM, Wang LW, Yuan JP, Chen JM, Yang F, Li Y*.Quantum dot-based multispectral fluorescent imaging to quantitatively study co-expressions of Ki67 and HER2 in breast cancer. experimental and molecular pathology. 2015,99(1):133-138.SCI
61. Yuan JP, Wang LW, Qu AP, Chen JM, Xiang QM, Chen C, Sun SR, Pang DW, Liu J, Li Y*.Quantum dots-based quantitative and in situ multiple imaging on Ki67 and cytokeratin to improve ki67 assessment in breast cancer. PLoS One. 2015,10(4):**.SCI
62. Wang LW, Peng CW, Chen C, Li Y*.Quantum dots-based tissue and in vivo imaging in breast cancer researches: current status and future perspectives. Breast Cancer Res Treat. 2015,151(1):7-17.SCI
63. Wang LW, Yang GF, Chen JM, Yang F, Yuan JP, Sun SR, Chen C, Hu MB, Li Y*.A Clinical Database of Breast Cancer Patients Reveals Distinctive Clinico-pathological Characteristics: a Study From Central China. Asian Pacific Journal of Cancer Prevention. 2014,15(4):1621-1626.SCI
64. Huang CQ, Yang XJ, Yu Y, Wu HT, Liu Y, Yonemura Y, Li Y*.Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy Improves Survival for Patients with Peritoneal Carcinomatosis from Colorectal Cancer: A Phase II Study from a Chinese Center. plos one. 2014,9(9):108509.SCI
65. Hu WQ, Wang LW, Yuan JP, Yan SG, Li JD, Zhao HL, Peng CW, Yang GF, Li Y*.High Expression of Transform Growth Factor Beta 1 in Gastric Cancer Confers Worse OutcomeResults of a Cohort Study on 184 Patients. Hepatogastroenterology. 2014,61(129):245-50.SCI
66. Zeng WJ, Hu WQ, Wang LW, Yan SG, Li JD1, Zhao HL, Peng CW, Yang GF, Li Y*.Long term follow up and retrospective study on 533 gastric cancer cases. BMC Surg. 2014,14(29):2-8.SCI
67. Peng CW, Wang LW, Zeng WJ, Yang XJ, Li Y*.Evaluation of the staging systems for gastric cancer.. Journal of Surgical Oncology. 2013,108(2):93-105.SCI
68. Zeng WJ, Hu WQ, Wang LW, Yan SG, Li JD, Zhao HL, Peng CW, Yang GF, Li Y*.Lymph node ratio is a better prognosticator than lymph node status for gastric cancer: A retrospective study of 138 cases. ONCOLOGY LETTERS. 2013,6(6):1693-1700.SCI
69. Fang M, Yuan JP, Peng CW, Pang DW, Li Y*.Quantum dots-based in situ molecular imaging of dynamic changes of collagen IV during cancer invasion. Biomaterials. 2013,34(34):8708e8717.SCI
70. Fang M, Yuan J, Peng C, Li Y*.Collagen as a double-edged sword in tumor progression. Tumor Biol.. 2013,35(4):2871-82.SCI
71. Huang CQ, Feng JP, Yang XJ, Li Y*.Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from colorectal cancer: a case-control study from a Chinese center.. Journal of Surgical Oncology. 2013,109(7):23545.SCI
72. Zhong YJ, Shao LH, Li Y*.Cathepsin B-cleavable doxorubicin prodrugs for targeted cancer therapy. INTERNATIONAL JOURNAL OF ONCOLOGY. 2013,42(2):373-383.SCI
73. Fang M, Peng CW, Yuan JP, Zhang ZL, Pang DW, Li Y*.Coevolution of the tumor microenvironment revealed by quantum dot-based multiplexed imaging of hepatocellular carcinoma. Future Oncol. 2013,9(7):1029–1037.SCI
主编或副主编的著作/译著
1. 《腹膜表面恶性肿瘤细胞减灭术与围手术化疗》,主译,科学出版社,2018
2.
3. 《影像引导下的癌症诊断和治疗》,主译,人民卫生出版社(北京),200504
重要奖项
1. 第七届首都十大健康卫士提名奖 第七届首都十大健康卫士提名奖 提名奖 201908
2. 首都医科大学附属北京世纪坛医院2017年度院科学技术奖 首都医科大学附属北京世纪坛医院2017年度院科学技术奖 一等奖 201807
3. 2017人民好医生年度人物 人民好医生 20172
4. 2016年度先进工作者 先进工作者 201708
5. 第三届中央人民广播电台“京城好医生”活动 优秀好医生 201612
6. “敬佑生命2016荣耀医者”公益评选 专科精英奖 201611
7. Top 8 Abstract award at the 10th International Congress on Peritoneal Surface Malignancies. TOP 8 Abstract 201611
8. 国务院政府特殊津贴 201501
9. 腹膜癌综合诊疗技术体系的建立和应用 湖北省科技进步奖 一等奖 201501
10. 湖北省卫计委“人民好医生”荣誉称号 201405
11. 湖北省首届医学领军人才培养工程入选者 201310
12. 武汉大学医学部医学突出贡献奖 201301
13. 武汉大学医学部医学突出贡献奖 201201
14. 靶向嵌合启动子系统抗肿瘤作用的系列研究 湖北省科技进步奖 一等奖 201112
15. 国际发展与教育奖 美国临床肿瘤学会国际发展与教育奖 2008
16. 欧洲肿瘤学会发展中国家旅行奖 200706
17. 转移性人肝癌模型系统的建立及其在肝癌转移研究中的应用 国家科学技术进步奖 一等奖 200702
18. 《转移性人肝癌细胞模型的优化及转移机理探讨》 上海市研究生优秀成果（学位论文） 200501
19. 胃肠癌患者围手术期应用西米替丁对细胞免疫指标和肿瘤细胞异质性的影响 湖北省科技进步奖 二等奖 200412
20. 《转移性人肝癌细胞模型的优化及转移机理探讨》 全国优秀博士学位论文 优秀 200409
21. 武汉大学医学院第二届青年教师演讲比赛 三等奖 200405
22. 《细胞角质蛋白19与肝癌病理进展关系的探讨》 第三次全国肿瘤中青年医学学术交流会优秀论文 一等奖 200312
23. 武汉大学中南医院中青年教师教学竞赛 第一名 200312